Evidence map›Paper›PMID 41304814›Full record

ArticlePharmaceutics2025

Screening-Identified Oxazole-4-Carboxamide KB-2777 Exhibits In Vitro Anti-Coronavirus Activity.

Bud Jung, Woonsung Na, Minjoo Yeom, Jong-Woo Lim, Hai Quynh Do, Geonhee Jang, Min-A Ban, Ji-Eun Yang, Youngjoo Byun, Daesub Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bud JungDepartment of Pharmacy, College of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Woonsung NaDepartment of Oral Microbiology and Immunology, School of Dentistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0002-7254-5240
Minjoo YeomDepartment of Virology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
Jong-Woo LimDepartment of Virology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
Hai Quynh DoDepartment of Virology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.
Geonhee JangDepartment of Pharmacy, College of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Min-A BanDepartment of Pharmacy, College of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Ji-Eun YangDepartment of Pharmacy, College of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
Youngjoo ByunInterdisciplinary Major Program in Innovative Pharmaceutical Sciences, Korea University, Sejong 30019, Republic of Korea.ORCID 0000-0002-0297-7734
Daesub SongDepartment of Virology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea.

Funding

National Research Foundation of Korea (NRF) RS-2019-NR040070
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

combination therapyHCoV-NL63HCoV-OC43oxazole-4-carboxamidePEDVtime-of-addition

Identifiers

PMID41304814
PMCPMC12655682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.